For Healthcare Professionals
News
New! Real World Evidence across nearly 4,000 adult users demonstrates best in class* hypoglycaemia, the lowest glycaemic variability, with strong time in range across age groups
Join our Webinars
Join us for upcoming educational webinar series taking a closer look at Kaleido’s clinical evidence, technology, and how it can help optimise glycaemic control for your patients.
Introducing new real-world data and how the Kaleido system helps to achieve glycaemic outcomes for adults with type 1 diabetes – In German
October 22 at 19:00-20:00 CET
Translating Real-World Data and optimising therapy settings – In German
October 27th at 18:00-20:00 CET
Translating Real-World Data and optimising therapy settings – In German
November 25th at 18:00 – 20:00 CET
“Ask the Expert” live interactive session with Dr. Arndt. Come prepared with Yourloops data reports – In German
January 2027 – Date to be defined
Feel free to bring your questions and any topics you’d like to discuss – we’ll shape the content together with you!
The Kaleido Difference
Proprietary Valve Microdosing Mechanism
Designed for precise, non-pressurised, and consistent insulin delivery
Reproducible insulin delivery
at the lowest bolus dose5
Basal and bolus dose accuracy
within +/- 5% of target6
All-Around Glycaemic Control in Real-World Use
Best-in-class time below range; 1.23% time below 70 mg/dL (3.9 mmol/L); only 18 mins per day1; 0.21% time spent below 54 mg/dL (3.0 mmol/L); only 3 mins per day1
Lowest published Coefficient of Variation Data (CV); 28.7% median CV published in the real-world1,2
No compromise on strong time in range; 72.2% Median time in range meets consensus targets1,3,4
The Smallest, Lightest, Insulin Patch Pump In Its Class*
The Smallest, Lightest, Insulin Pump In Its Class*
Discreet, Personalised form factor weighs only 19 grams. Available in 10 colour combinations.
Smartphone controlled and connected with the Dexcom G7
Controlled from the Smartphone of the user.
Educational Materials
-
Software version 2.6.0 REV2Software version 2.6.0 REV2
-
Software version 2.6.0 REV1Software version 2.6.0 REV1
-
Software version 2.5.0Software version 2.5.0
-
Software version 2.4.0Software version 2.4.0
User guides Diabeloop DBLG1
User guide DBLG1 REV9 mg/dL (1.18)
User guide DBLG1 REV3 mmol/L (1.18)
More...
User guide DBLG1 REV9 mg/dL (1.18)
User guide DBLG1 REV3 mmol/L (1.18)
More...
-
User guide DBLG1 REV8 mg/dLUser guide DBLG1 REV8 mg/dL
-
User guide DBLG1 REV7 mg/dLUser guide DBLG1 REV7 mg/dL
-
User guide DBLG1 REV5 mg/dLUser guide DBLG1 REV5 mg/dL
-
Complete overview DBLG1 user guidesComplete overview DBLG1 user guides
User guides Diabeloop DBLG2
-
User guide DBLG2 REV 3 mg/dLUser guide DBLG2 REV 3 mg/dL
-
User guide DBLG2 REV 3 mmol/LUser guide DBLG2 REV 3 mmol/L
User guide Kaleido Controller
-
Kaleido ControllerKaleido Controller
Brochures
-
Kaleido with DBLG2 BrochureKaleido with DBLG2 Brochure
Contact
Kaleido
*Kaleido data on file. DCR 920379-02
1.Storms et al., “Glycaemic variability and real-world glycaemic control with the Kaleido insulin patch pump and DBLG1 AID algorithm,” EASD 2026 Late-Breaking Abstract LBA-26-4677-EASD. 2. Kaleido data on file 3. ADA Standards of Care; doi.org/10.2337/dc25-S006 4. doi: 10.2337/dc17-1600 5.Manufacturers’ IFU as of September 24, 2026. 6. Kaleido data on file